MetLife Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-18,164
| Closed | -$111K | – | 2606 |
|
2021
Q3 | $111K | Buy |
18,164
+12,336
| +212% | +$75.2K | ﹤0.01% | 2398 |
|
2021
Q2 | $48K | Sell |
5,828
-12,882
| -69% | -$106K | ﹤0.01% | 2423 |
|
2021
Q1 | $167K | Buy |
18,710
+8,641
| +86% | +$77.3K | ﹤0.01% | 2144 |
|
2020
Q4 | $116K | Sell |
10,069
-9,786
| -49% | -$113K | ﹤0.01% | 2209 |
|
2020
Q3 | $207K | Buy |
19,855
+4,337
| +28% | +$45.1K | ﹤0.01% | 1849 |
|
2020
Q2 | $204K | Hold |
15,518
| – | – | ﹤0.01% | 1891 |
|
2020
Q1 | $122K | Hold |
15,518
| – | – | ﹤0.01% | 1970 |
|
2019
Q4 | $321K | Hold |
15,518
| – | – | ﹤0.01% | 1702 |
|
2019
Q3 | $213K | Hold |
15,518
| – | – | ﹤0.01% | 1910 |
|
2019
Q2 | $191K | Hold |
15,518
| – | – | ﹤0.01% | 2056 |
|
2019
Q1 | $194K | Hold |
15,518
| – | – | ﹤0.01% | 1998 |
|
2018
Q4 | $176K | Hold |
15,518
| – | – | ﹤0.01% | 1979 |
|
2018
Q3 | $290K | Hold |
15,518
| – | – | ﹤0.01% | 1877 |
|
2018
Q2 | $401K | Hold |
15,518
| – | – | ﹤0.01% | 1541 |
|
2018
Q1 | $348K | Hold |
15,518
| – | – | ﹤0.01% | 1598 |
|
2017
Q4 | $389K | Buy |
+15,518
| New | +$389K | ﹤0.01% | 1548 |
|